Seagen Inc. (SGEN) SEC Filing 8-K Material Event for the period ending Tuesday, April 12, 2022

Seattle Genetics Inc Wa

CIK: 1060736 Ticker: SGEN

View differences made from one to another to evaluate Seattle Genetics Inc Wa's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Seattle Genetics Inc Wa.


Assess how Seattle Genetics Inc Wa's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Seattle Genetics Inc Wa's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Seattle Genetics Inc Wa provided additional information to their SEC Filing as exhibits

Ticker: SGEN
CIK: 1060736
Form Type: 8-K Corporate News
Accession Number: 0001193125-22-106857
Submitted to the SEC: Fri Apr 15 2022 4:35:58 PM EST
Accepted by the SEC: Fri Apr 15 2022
Period: Tuesday, April 12, 2022
Industry: Biological Products No Disgnostic Substances
  1. Bylaw Change
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: